VYGR News and Press, Voyager Therapeutics Inc. From 08/03/23

2023-08-03 13:26:09 ET Start Time: 08:30 End Time: 09:08 Voyager Therapeutics, Inc. (VYGR) Q2 2023 Earnings Conference Call August 03, 2023, 08:30 AM ET Company Participants Al Sandrock - President and CEO Pete Pfreundschuh - CFO Todd Carter - Chief Scien...

2023-08-03 07:09:18 ET Voyager Therapeutics press release ( NASDAQ: VYGR ): Q2 GAAP EPS of -$0.51 beats by $0.06 . Revenue of $4.85M (+583.1% Y/Y) beats by $3.25M . For further details see: Voyager Therapeutics GAAP EPS of -$0.51 beats by $0.06, revenue o...

- Introduced new vectorized anti-Aβ antibody gene therapy research initiative, expanding Alzheimer’s disease portfolio - - Executed license agreement with Sangamo for prion disease treatment - - Presented validating preclinical results including increased brain tra...

2023-08-02 16:16:01 ET Voyager Therapeutics ( NASDAQ: VYGR ) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open. The consensus EPS Estimate is -$0.56 and the consensus Revenue Estimate is $1.6M. Over the last 3 months, EPS estimate...

CAMBRIDGE, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that Chief Scientific Officer Todd Carter, Ph.D., and Chief Financial Officer Peter Pfreunds...

2023-07-31 14:43:42 ET Summary Two new Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. This week two of four picks gained over 10% in less than a week with peak gains in CLLS +16.8% AUTL+15.5% but the portfolio failed...

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report second quarter 2023 financial and operating results before the market opens on...

2023-07-14 05:40:00 ET When looking for stocks that can make one richer, investors often start with names they know. The problem is that the names they know also tend to be the names that everyone knows, and these stocks tend to be valued in such a way that they wouldn't be considered barga...

2023-07-11 17:30:00 ET Summary Voyager Therapeutics, a biotech firm specializing in gene therapy and neurology, has seen significant financial growth in Q1 2023 due to strategic partnerships with Novartis and Neurocrine Biosciences. The company is developing drug candidates for ne...

2023-06-21 10:07:44 ET Gainers: Ocean Biomedical ( OCEA ) +43% . PetVivo Holdings ( PETV ) +23% . Patterson Companies ( PDCO ) +14% . Zentalis Pharmaceuticals ( ZNTL ) +5% . RenovoRx ( RNXT ) +4% . Losers: uniQure ( ...